Security Snapshot

ClearPoint Neuro, Inc. - Common Stock, $0.01 par value per share (CLPT) Institutional Ownership

CUSIP: 18507C103

13F Institutional Holders and Ownership History from Q1 2020 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

116

Shares (Excl. Options)

12,978,078

Price

$9.10

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+1,714,334
Value change
+$9,409,526
Number of holders
116
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
30,182,365
SEC-reported price per share
$12.24
Insider filing price
$12.24
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CLPT - ClearPoint Neuro, Inc. - Common Stock, $0.01 par value per share is tracked under CUSIP 18507C103.
  • 116 institutions reported positions in Q1 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 119 to 116 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $154,607,785 to $118,095,122.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 116 institutions filings for Q1 2026.

Open SEC evidence

Security key

18507C103

Latest holder period

Q1 2026

13F holders

116

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
CLPT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIGGER CAPITAL FUND L P 7.8% +2.5% $30,322,308 +$967,532 2,216,543 +3.3% Bigger Michael 31 Dec 2025
MAK Capital Fund LP 6.3% +3.3% $17,436,654 +$1,576,121 1,901,489 +9.9% MAK Capital Fund LP 31 Mar 2026
BlackRock, Inc. 5.6% $24,352,856 1,583,071 BlackRock, Inc. 30 Jun 2025

As of 31 Mar 2026, 116 institutional investors reported holding 12,978,078 shares of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value per share (CLPT). This represents 43% of the company’s total 30,182,365 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
38%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 6.9% 2,082,750 +1.9% 0% $18,953,026
MAK CAPITAL ONE LLC 6.3% 1,901,489 2.9% $17,303,550
VANGUARD CAPITAL MANAGEMENT LLC 4.1% 1,243,615 0% 0% $11,316,897
GEODE CAPITAL MANAGEMENT, LLC 2.3% 705,720 +7.9% 0% $6,423,798
STATE STREET CORP 2.3% 679,819 +8.2% 0% $6,186,353
Lane Generational LLC 1.6% 486,849 +43% 3.5% $4,430,326
GOLDMAN SACHS GROUP INC 1.5% 463,617 +60% 0% $4,218,915
UBS Group AG 1.4% 432,360 +27% 0% $3,934,476
SG Americas Securities, LLC 1.2% 372,356 0% $3,388,000
BROWN ADVISORY INC 1.1% 325,906 -1.5% 0% $2,965,745
VANGUARD PORTFOLIO MANAGEMENT LLC 0.94% 284,809 0% 0% $2,591,762
MILLENNIUM MANAGEMENT LLC 0.77% 231,974 -55% 0% $2,110,963
DEUTSCHE BANK AG\ 0.77% 230,941 +1.2% 0% $2,101,564
TWO SIGMA INVESTMENTS, LP 0.7% 210,780 -3.9% 0% $1,918,098
NORTHERN TRUST CORP 0.69% 209,426 +8.3% 0% $1,905,777
Massar Capital Management, LP 0.69% 206,970 +17% 0.38% $1,883,427
VANGUARD FIDUCIARY TRUST CO 0.68% 205,755 0% 0% $1,872,371
TUDOR INVESTMENT CORP ET AL 0.52% 156,971 0.01% $1,428,436
CM Management, LLC 0.5% 150,000 +88% 1.1% $1,365,000
PARSONS CAPITAL MANAGEMENT INC/RI 0.49% 149,170 +1.3% 0.06% $1,357,447
Bank of New York Mellon Corp 0.48% 143,747 +40% 0% $1,308,101
Pekin Hardy Strauss, Inc. 0.47% 140,375 0.13% $1,277,412
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.45% 136,284 -9.5% 0% $1,240,185
Taylor Frigon Capital Management LLC 0.44% 131,901 -0.39% 0.68% $1,200,299
MORGAN STANLEY 0.43% 129,872 +15% 0% $1,181,835

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
25
Latest
Q1 2026
Rows shown
1-25 of 25
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 12,978,078 $118,095,122 +$9,409,526 $9.10 116
2025 Q4 11,301,752 $154,607,785 +$8,981,341 $13.68 119
2025 Q3 9,852,347 $214,616,813 +$19,210,930 $21.79 106
2025 Q2 9,158,528 $109,328,754 +$14,491,053 $11.94 96
2025 Q1 8,192,663 $97,509,520 +$5,576,522 $11.89 101
2024 Q4 7,604,982 $116,965,932 +$12,952,321 $15.38 89
2024 Q3 6,824,887 $76,506,571 -$722,998 $11.21 78
2024 Q2 7,054,815 $38,032,671 -$3,182,534 $5.39 82
2024 Q1 7,537,566 $51,255,965 +$8,355,957 $6.80 80
2023 Q4 6,294,172 $42,743,970 +$2,471,846 $6.79 69
2023 Q3 5,945,334 $29,812,011 +$1,413,167 $5.01 62
2023 Q2 5,807,940 $42,048,347 +$7,782,251 $7.24 60
2023 Q1 4,610,777 $38,915,035 +$3,180,292 $8.44 59
2022 Q4 4,233,376 $36,002,568 +$2,658,961 $8.47 62
2022 Q3 3,823,775 $39,609,709 +$2,929,976 $10.36 52
2022 Q2 3,481,751 $45,435,169 -$14,747,696 $13.05 44
2022 Q1 4,754,849 $49,447,250 -$533,820 $10.41 61
2021 Q4 4,769,266 $53,493,964 -$12,166,751 $11.22 65
2021 Q3 5,487,089 $97,479,919 +$2,463,812 $17.75 68
2021 Q2 5,322,434 $101,536,402 +$42,321,910 $19.09 75
2021 Q1 3,102,980 $65,594,982 +$19,961,387 $21.14 50
2020 Q4 2,274,660 $36,144,244 +$16,455,073 $15.89 38
2020 Q3 992,026 $5,416,000 -$335,510 $5.46 25
2020 Q2 1,142,056 $4,063,000 -$489,528 $3.56 24
2020 Q1 1,278,400 $4,646,000 +$4,642,000 $3.59 25
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .